Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. (Record no. 30443334)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02315 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518074859.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202101s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1527-7755 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1200/JCO.19.03011 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hourigan, Christopher S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20210127 |
| 245 00 - TITLE STATEMENT | |
| Title | Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Date of publication, distribution, etc. | 04 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1273-1283 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Circulating Tumor DNA |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials, Phase III as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hematopoietic Stem Cell Transplantation |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | High-Throughput Nucleotide Sequencing |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Myeloid, Acute |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm, Residual |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transplantation Conditioning |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transplantation, Homologous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dillon, Laura W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gui, Gege |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Logan, Brent R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fei, Mingwei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghannam, Jack |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Yuesheng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Licon, Abel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Alyea, Edwin P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bashey, Asad |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deeg, H Joachim |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Devine, Steven M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fernandez, Hugo F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Giralt, Sergio |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hamadani, Mehdi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Howard, Alan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Maziarz, Richard T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Porter, David L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Scott, Bart L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Warlick, Erica D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pasquini, Marcelo C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Horwitz, Mitchell E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Related parts | vol. 38 |
| -- | no. 12 |
| -- | p. 1273-1283 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.19.03011">https://doi.org/10.1200/JCO.19.03011</a> |
| Public note | Available from publisher's website |
No items available.